Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution
 Back to Details

Connection

Gareth Morgan to Adult

This is a "connection" page, showing publications Gareth Morgan has written about Adult.

 
Connection Strength
  
 
 
0.925
  
  1. Vargas-Acevedo C, Zablah JE, Mejía E, Soszyn N, Kay J, Morgan GJ. Characterizing the Acute Changes in Pulmonary Capillary Wedge Pressure Associated With Transcatheter Pulmonary Valve Replacement. Catheter Cardiovasc Interv. 2025 Oct; 106(4):2724-2733.
    View in: PubMed
    Score: 0.048
  2. Vargas-Acevedo C, Mejia E, Zablah JE, Morgan GJ. Fusion imaging for guidance of pulmonary arteriovenous malformation embolisation with minimal radiation and contrast exposure. Cardiol Young. 2024 Jul; 34(7):1451-1455.
    View in: PubMed
    Score: 0.043
  3. Morgan GJ, Zablah J. A new FDA approved stent for congenital heart disease: First-in-man experiences with G-ARMORTM. Catheter Cardiovasc Interv. 2022 12; 100(7):1261-1266.
    View in: PubMed
    Score: 0.040
  4. Boyle EM, Williams L, Blaney P, Ashby C, Bauer M, Walker BA, Ghamlouch H, Choi J, Perrial E, Wang Y, Caro J, Stoeckle JH, Arbini A, Kaminetzky D, Braunstein M, Bruno B, Razzo B, Diamond B, Maclachlan K, Maura F, Landgren O, Litke R, Fegan CD, Keats J, Auclair D, Davies FE, Morgan GJ. Improving prognostic assignment in older adults with multiple myeloma using acquired genetic features, clonal hemopoiesis and telomere length. Leukemia. 2022 01; 36(1):221-224.
    View in: PubMed
    Score: 0.036
  5. Shahanavaz S, Aldoss O, Carr K, Gordon B, Seckeler MD, Hiremath G, Seaman C, Zablah J, Morgan G. Acute and medium term results of balloon expandable stent placement in the transverse arch-a multicenter pediatric interventional cardiology early career society study. Catheter Cardiovasc Interv. 2020 11; 96(6):1277-1286.
    View in: PubMed
    Score: 0.034
  6. Morgan GJ, Sivakumar K, Promphan W, Goreczny S, Prachasilchai P, Qureshi S. Early clinical experience with the straight design of Venus P-valve? in dysfunctional right ventricular outflow tracts. Catheter Cardiovasc Interv. 2020 11; 96(6):E653-E659.
    View in: PubMed
    Score: 0.033
  7. Nishimura KK, Barlogie B, van Rhee F, Zangari M, Walker BA, Rosenthal A, Schinke C, Thanendrarajan S, Davies FE, Hoering A, Morgan GJ. Long-term outcomes after autologous stem cell transplantation for multiple myeloma. Blood Adv. 2020 Jan 28; 4(2):422-431.
    View in: PubMed
    Score: 0.033
  8. Morgan GJ, Sadeghi S, Salem MM, Wilson N, Kay J, Rothman A, Galindo A, Martin MH, Gray R, Ross M, Aboulhosn JA, Levi DS. SAPIEN valve for percutaneous transcatheter pulmonary valve replacement without "pre-stenting": A multi-institutional experience. Catheter Cardiovasc Interv. 2019 02 01; 93(2):324-329.
    View in: PubMed
    Score: 0.030
  9. Morgan GJ, Pushparajah K, Narayan S, Rosenthal E. Large Calibre Self-Expanding Stents for Pulmonary Stenosis After the Arterial Switch, a Low-Risk Solution to a Low-Flow Situation. Pediatr Cardiol. 2018 Apr; 39(4):824-828.
    View in: PubMed
    Score: 0.029
  10. Morgan GJ, Ciuffreda M, Spadoni I, DeGiovanni J. Optimus covered stent: Advanced covered stent technology for complex congenital heart disease. Congenit Heart Dis. 2018 May; 13(3):458-462.
    View in: PubMed
    Score: 0.029
  11. Morgan GJ, Kenny D, Duke C, Walsh KP, Qureshi SA. Initial assessment of a novel delivery system (NuDEL? ®) for the covered Cheatham-Platinum stent. Cardiol Young. 2017 Oct; 27(8):1465-1469.
    View in: PubMed
    Score: 0.028
  12. Husain J, Praichasilchai P, Gilbert Y, Qureshi SA, Morgan GJ. Early European experience with the Venus P-valve®: filling the gap in percutaneous pulmonary valve implantation. EuroIntervention. 2016 Aug 05; 12(5):e643-51.
    View in: PubMed
    Score: 0.026
  13. Pawlyn C, Kaiser MF, Heuck C, Melchor L, Wardell CP, Murison A, Chavan SS, Johnson DC, Begum DB, Dahir NM, Proszek PZ, Cairns DA, Boyle EM, Jones JR, Cook G, Drayson MT, Owen RG, Gregory WM, Jackson GH, Barlogie B, Davies FE, Walker BA, Morgan GJ. The Spectrum and Clinical Impact of Epigenetic Modifier Mutations in Myeloma. Clin Cancer Res. 2016 Dec 01; 22(23):5783-5794.
    View in: PubMed
    Score: 0.025
  14. Walker BA, Wardell CP, Murison A, Boyle EM, Begum DB, Dahir NM, Proszek PZ, Melchor L, Pawlyn C, Kaiser MF, Johnson DC, Qiang YW, Jones JR, Cairns DA, Gregory WM, Owen RG, Cook G, Drayson MT, Jackson GH, Davies FE, Morgan GJ. APOBEC family mutational signatures are associated with poor prognosis translocations in multiple myeloma. Nat Commun. 2015 Apr 23; 6:6997.
    View in: PubMed
    Score: 0.023
  15. Allen SJ, Jordan S, Storey M, Thornton CA, Gravenor MB, Garaiova I, Plummer SF, Wang D, Morgan G. Probiotics in the prevention of eczema: a randomised controlled trial. Arch Dis Child. 2014 Nov; 99(11):1014-9.
    View in: PubMed
    Score: 0.022
  16. Smith B, Thomson J, Crossland D, Spence MS, Morgan GJ. UK multicenter experience using the Gore septal occluder (GSO(TM) ) for atrial septal defect closure in children and adults. Catheter Cardiovasc Interv. 2014 Mar 01; 83(4):581-6.
    View in: PubMed
    Score: 0.021
  17. Morgan GJ, Lee KJ, Chaturvedi R, Bradley TJ, Mertens L, Benson L. Systemic blood pressure after stent management for arch coarctation implications for clinical care. JACC Cardiovasc Interv. 2013 Feb; 6(2):192-201.
    View in: PubMed
    Score: 0.020
  18. Morgan GJ, Davies FE, Gregory WM, Szubert AJ, Bell SE, Drayson MT, Owen RG, Ashcroft AJ, Jackson GH, Child JA. Effects of induction and maintenance plus long-term bisphosphonates on bone disease in patients with multiple myeloma: the Medical Research Council Myeloma IX Trial. Blood. 2012 Jun 07; 119(23):5374-83.
    View in: PubMed
    Score: 0.019
  19. Morgan GJ, Child JA, Gregory WM, Szubert AJ, Cocks K, Bell SE, Navarro-Coy N, Drayson MT, Owen RG, Feyler S, Ashcroft AJ, Ross FM, Byrne J, Roddie H, Rudin C, Cook G, Jackson GH, Wu P, Davies FE. Effects of zoledronic acid versus clodronic acid on skeletal morbidity in patients with newly diagnosed multiple myeloma (MRC Myeloma IX): secondary outcomes from a randomised controlled trial. Lancet Oncol. 2011 Aug; 12(8):743-52.
    View in: PubMed
    Score: 0.018
  20. Morgan GJ, Davies FE, Gregory WM, Cocks K, Bell SE, Szubert AJ, Navarro-Coy N, Drayson MT, Owen RG, Feyler S, Ashcroft AJ, Ross F, Byrne J, Roddie H, Rudin C, Cook G, Jackson GH, Child JA. First-line treatment with zoledronic acid as compared with clodronic acid in multiple myeloma (MRC Myeloma IX): a randomised controlled trial. Lancet. 2010 Dec 11; 376(9757):1989-99.
    View in: PubMed
    Score: 0.017
  21. Davies FE, Wu P, Jenner M, Srikanth M, Saso R, Morgan GJ. The combination of cyclophosphamide, velcade and dexamethasone induces high response rates with comparable toxicity to velcade alone and velcade plus dexamethasone. Haematologica. 2007 Aug; 92(8):1149-50.
    View in: PubMed
    Score: 0.014
  22. Beer SA, Cairns DA, Pawlyn C, Holroyd A, Ferris E, Cook G, Drayson M, Boyd K, Proszek P, Davies FE, de Tute R, Jenner M, Morgan GJ, Owen R, Hubank M, Houlston R, Jackson G, Kaiser MF. Challenging the concept of functional high-risk myeloma through transcriptional and genetic profiling. Blood. 2025 Nov 27; 146(22):2670-2680.
    View in: PubMed
    Score: 0.012
  23. Luetkemeyer AF, Chew KW, Lacey S, Hughes MD, Harrison LJ, Daar ES, Eron J, Fletcher CV, Greninger AL, Hessinger D, Li JZ, Mailhot D, Wohl D, Chayakulkeeree M, Mendoza JLA, Elistratova P, Makinde O, Morgan G, Portsmouth S, Uehara T, Smith D, Currier JS. Ensitrelvir for the Treatment of Nonhospitalized Adults with COVID-19: Results from the SCORPIO-HR, Phase 3, Randomized, Double-blind, Placebo-Controlled Trial. Clin Infect Dis. 2025 Jul 18; 80(6):1235-1244.
    View in: PubMed
    Score: 0.012
  24. Varma G, Fogel L, Gordon B, Saldarriaga MM, Ahn J, Aleman A, Caro J, Rosenberg MC, Monge J, Parmar H, Kaminetzky D, Moskovits T, Siegel DS, Morgan GJ, Niesvizky R, Davies FE, Biran N. Real-world safety and efficacy of teclistamab in relapsed/refractory multiple myeloma: results from a multicenter, retrospective study and descriptive meta-analysis. Leuk Lymphoma. 2025 May; 66(5):942-951.
    View in: PubMed
    Score: 0.011
  25. Rosenthal E, Qureshi SA, Sivakumar K, Jones M, Yong SF, Kabir S, Sagar P, Thejaswi P, Hascoet S, Batteux C, Boudjemline Y, Hijazi ZM, Aboulhosn JA, Levi DS, Salem MM, Francis E, Kempny A, Fraisse A, Bautista-Rodriguez C, Walsh K, Kenny D, Traynor B, Al Maskari SN, Bentham JR, Környei L, Sivaprakasam MC, Firouzi A, Khajali Z, Benson L, Osten M, Baruteau AE, Crystal MA, Forbes TJ, Georgiev S, Sievert H, Tin DN, Springmuller D, Subramanian A, Abdullah HAM, Bedair R, Chamié F, Celebi A, Damsky Barbosa J, De Meester P, Giugno L, Jalal Z, Karsenty C, Schleiger A, Fleming G, Jakob A, Karagoaz T, Mainzer G, Morgan GJ, Narin N, Shahanavaz S, Steinberg ZL, Aldoss O, Alizade E, Aregullin O, Bouvaist H, Fleck T, Godart F, Malekzadeh-Milani S, Motta P, Sanchez-Recalde A, Sandoval JP, Tan W, Thomson J, Tomé Teixeirense P, Zahn EM. Covered Stent Correction for Sinus Venosus Atrial Septal Defects, an Emerging Alternative to Surgical Repair: Results of an International Registry. Circulation. 2025 Mar 18; 151(11):744-756.
    View in: PubMed
    Score: 0.011
  26. Dimas VV, Babaliaros V, Kim D, Lim DS, Morgan G, Jones TK, Armstrong AK, Berman D, Aboulhosn J, Mahadevan VS, Gillespie MJ, Balzer D, Zellers T, Yu X, Shirali G, Parthiban A, Leipsic J, Blanke P, Zahn E, Shahanavaz S. Multicenter Pivotal Study of the Alterra Adaptive Prestent for the Treatment of Pulmonary Regurgitation. JACC Cardiovasc Interv. 2024 Oct 14; 17(19):2287-2297.
    View in: PubMed
    Score: 0.011
  27. Qureshi AM, Sommer RJ, Morgan G, Paolillo JA, Gray RG, Love B, Goldstein BH, Sugeng L, Gillespie MJ. Long-Term Results of the Atrial Septal Defect Occluder ASSURED Trial for Combined Pivotal/Continued Access Cohorts. JACC Cardiovasc Interv. 2024 Oct 14; 17(19):2274-2283.
    View in: PubMed
    Score: 0.011
  28. Arnold KD, Ong KL, Ravi G, Cutshall H, Purnell K, Wessel MC, Godby KN, Bal S, Giri S, Rogers LQ, Demark-Wahnefried W, Davies FE, Costa LJ, Morgan GJ, Birmann BM, Brown EE. Anthropometric traits and risk of multiple myeloma: differences by race, sex and diagnostic clinical features. Br J Cancer. 2024 Jul; 131(2):312-324.
    View in: PubMed
    Score: 0.011
  29. Skibola CF, Smith MT, Hubbard A, Shane B, Roberts AC, Law GR, Rollinson S, Roman E, Cartwright RA, Morgan GJ. Polymorphisms in the thymidylate synthase and serine hydroxymethyltransferase genes and risk of adult acute lymphocytic leukemia. Blood. 2002 May 15; 99(10):3786-91.
    View in: PubMed
    Score: 0.010
  30. Rodriguez SA, Morgan GJ, Lara C, Zablah JE. Baseline Values of the Compensatory Reserve Index in a Healthy Pediatric Population. Pediatr Cardiol. 2022 Feb; 43(2):344-349.
    View in: PubMed
    Score: 0.009
  31. Boyle EM, Deshpande S, Tytarenko R, Ashby C, Wang Y, Bauer MA, Johnson SK, Wardell CP, Thanendrarajan S, Zangari M, Facon T, Dumontet C, Barlogie B, Arbini A, Rustad EH, Maura F, Landgren O, Zhan F, van Rhee F, Schinke C, Davies FE, Morgan GJ, Walker BA. The molecular make up of smoldering myeloma highlights the evolutionary pathways leading to multiple myeloma. Nat Commun. 2021 01 12; 12(1):293.
    View in: PubMed
    Score: 0.009
  32. Jackson GH, Pawlyn C, Cairns DA, de Tute RM, Hockaday A, Collett C, Jones JR, Kishore B, Garg M, Williams CD, Karunanithi K, Lindsay J, Rocci A, Snowden JA, Jenner MW, Cook G, Russell NH, Drayson MT, Gregory WM, Kaiser MF, Owen RG, Davies FE, Morgan GJ. Carfilzomib, lenalidomide, dexamethasone, and cyclophosphamide (KRdc) as induction therapy for transplant-eligible, newly diagnosed multiple myeloma patients (Myeloma XI+): Interim analysis of an open-label randomised controlled trial. PLoS Med. 2021 01; 18(1):e1003454.
    View in: PubMed
    Score: 0.009
  33. Shahanavaz S, Zahn EM, Levi DS, Aboulhousn JA, Hascoet S, Qureshi AM, Porras D, Morgan GJ, Bauser Heaton H, Martin MH, Keeshan B, Asnes JD, Kenny D, Ringewald JM, Zablah JE, Ivy M, Morray BH, Torres AJ, Berman DP, Gillespie MJ, Chaszczewski K, Zampi JD, Walsh KP, Julien P, Goldstein BH, Sathanandam SK, Karsenty C, Balzer DT, McElhinney DB. Transcatheter Pulmonary Valve Replacement With the Sapien Prosthesis. J Am Coll Cardiol. 2020 12 15; 76(24):2847-2858.
    View in: PubMed
    Score: 0.009
  34. Hope VD, McVeigh J, Begley E, Glass R, Edmundson C, Heinsbroek E, Kean J, Campbell J, Whitfield M, Morgan G, Acreman D, Smith J. Factors associated with hepatitis C and HIV testing uptake among men who inject image and performance enhancing drugs. Drug Alcohol Rev. 2021 05; 40(4):586-596.
    View in: PubMed
    Score: 0.009
  35. Hoang PH, Cornish AJ, Sherborne AL, Chubb D, Kimber S, Jackson G, Morgan GJ, Cook G, Kinnersley B, Kaiser M, Houlston RS. An enhanced genetic model of relapsed IGH-translocated multiple myeloma evolutionary dynamics. Blood Cancer J. 2020 10 14; 10(10):101.
    View in: PubMed
    Score: 0.009
  36. Bradbury CA, Craig Z, Cook G, Pawlyn C, Cairns DA, Hockaday A, Paterson A, Jenner MW, Jones JR, Drayson MT, Owen RG, Kaiser MF, Gregory WM, Davies FE, Child JA, Morgan GJ, Jackson GH. Thrombosis in patients with myeloma treated in the Myeloma IX and Myeloma XI phase 3 randomized controlled trials. Blood. 2020 08 27; 136(9):1091-1104.
    View in: PubMed
    Score: 0.008
  37. Schinke C, Boyle EM, Ashby C, Wang Y, Lyzogubov V, Wardell C, Qu P, Hoering A, Deshpande S, Ryan K, Thanendrarajan S, Mohan M, Yarlagadda N, Khan M, Choudhury SR, Zangari M, van Rhee F, Davies F, Barlogie B, Morgan G, Walker BA. Genomic analysis of primary plasma cell leukemia reveals complex structural alterations and high-risk mutational patterns. Blood Cancer J. 2020 06 19; 10(6):70.
    View in: PubMed
    Score: 0.008
  38. Bygrave C, Pawlyn C, Davies F, Craig Z, Cairns D, Hockaday A, Jenner M, Cook G, Drayson M, Owen R, Gregory W, Morgan G, Jackson G, Kaiser M. Early relapse after high-dose melphalan autologous stem cell transplant predicts inferior survival and is associated with high disease burden and genetically high-risk disease in multiple myeloma. Br J Haematol. 2021 05; 193(3):551-555.
    View in: PubMed
    Score: 0.008
  39. Ehrmann DE, Leopold DK, Phillips R, Shahi N, Campbell K, Ross M, Zablah JE, Moulton SL, Morgan G, Kim JS. The Compensatory Reserve Index Responds to Acute Hemodynamic Changes in Patients with Congenital Heart Disease: A Proof of Concept Study. Pediatr Cardiol. 2020 Aug; 41(6):1190-1198.
    View in: PubMed
    Score: 0.008
  40. Sommer RJ, Love BA, Paolillo JA, Gray RG, Goldstein BH, Morgan GJ, Gillespie MJ. ASSURED clinical study: New GORE® CARDIOFORM ASD occluder for transcatheter closure of atrial septal defect. Catheter Cardiovasc Interv. 2020 06 01; 95(7):1285-1295.
    View in: PubMed
    Score: 0.008
  41. Schäfer M, Browne LP, Jaggers J, Barker AJ, Morgan GJ, Ivy DD, Mitchell MB. Abnormal left ventricular flow organization following repair of tetralogy of Fallot. J Thorac Cardiovasc Surg. 2020 Oct; 160(4):1008-1015.
    View in: PubMed
    Score: 0.008
  42. Pawlyn C, Cairns D, Kaiser M, Striha A, Jones J, Shah V, Jenner M, Drayson M, Owen R, Gregory W, Cook G, Morgan G, Jackson G, Davies F. The relative importance of factors predicting outcome for myeloma patients at different ages: results from 3894 patients in the Myeloma XI trial. Leukemia. 2020 02; 34(2):604-612.
    View in: PubMed
    Score: 0.008
  43. Kenny D, Morgan GJ, Murphy M, AlAlwi K, Giugno L, Zablah J, Carminati M, Walsh K. Use of 65 cm large caliber Dryseal sheaths to facilitate delivery of the Edwards SAPIEN valve to dysfunctional right ventricular outflow tracts. Catheter Cardiovasc Interv. 2019 Sep 01; 94(3):409-413.
    View in: PubMed
    Score: 0.008
  44. Schäfer M, Browne LP, von Alvensleben JC, Mitchell MB, Morgan GJ, Ivy DD, Jaggers J. Ventricular interactions and electromechanical dyssynchrony after Ross and Ross-Konno operations. J Thorac Cardiovasc Surg. 2019 08; 158(2):509-517.
    View in: PubMed
    Score: 0.008
  45. Swinburn BA, Kraak VI, Allender S, Atkins VJ, Baker PI, Bogard JR, Brinsden H, Calvillo A, De Schutter O, Devarajan R, Ezzati M, Friel S, Goenka S, Hammond RA, Hastings G, Hawkes C, Herrero M, Hovmand PS, Howden M, Jaacks LM, Kapetanaki AB, Kasman M, Kuhnlein HV, Kumanyika SK, Larijani B, Lobstein T, Long MW, Matsudo VKR, Mills SDH, Morgan G, Morshed A, Nece PM, Pan A, Patterson DW, Sacks G, Shekar M, Simmons GL, Smit W, Tootee A, Vandevijvere S, Waterlander WE, Wolfenden L, Dietz WH. The Global Syndemic of Obesity, Undernutrition, and Climate Change: The Lancet Commission report. Lancet. 2019 02 23; 393(10173):791-846.
    View in: PubMed
    Score: 0.008
  46. Taggart NW, Gordon BM, Morgan GJ, Goldstein BH. Variation in Anticoagulation Practices in the Congenital Cardiac Catheterization Lab: Results of a Multinational PICES Survey. Pediatr Cardiol. 2019 Jan; 40(1):53-60.
    View in: PubMed
    Score: 0.007
  47. Campbell JP, Heaney JLJ, Pandya S, Afzal Z, Kaiser M, Owen R, Child JA, Gregory W, Morgan GJ, Jackson GH, Bunce CM, Drayson MT. Active multiple myeloma suppresses and typically eliminates coexisting MGUS. Br J Cancer. 2017 Sep 05; 117(6):835-839.
    View in: PubMed
    Score: 0.007
  48. Law PJ, Sud A, Mitchell JS, Henrion M, Orlando G, Lenive O, Broderick P, Speedy HE, Johnson DC, Kaiser M, Weinhold N, Cooke R, Sunter NJ, Jackson GH, Summerfield G, Harris RJ, Pettitt AR, Allsup DJ, Carmichael J, Bailey JR, Pratt G, Rahman T, Pepper C, Fegan C, von Strandmann EP, Engert A, Försti A, Chen B, Filho MI, Thomsen H, Hoffmann P, Noethen MM, Eisele L, Jöckel KH, Allan JM, Swerdlow AJ, Goldschmidt H, Catovsky D, Morgan GJ, Hemminki K, Houlston RS. Genome-wide association analysis of chronic lymphocytic leukaemia, Hodgkin lymphoma and multiple myeloma identifies pleiotropic risk loci. Sci Rep. 2017 01 23; 7:41071.
    View in: PubMed
    Score: 0.007
  49. Goreczny S, Morgan GJ, Dryzek P, Moll JA, Moszura T. Initial experience with live three-dimensional image overlay for ductal stenting in hypoplastic left heart syndrome. EuroIntervention. 2016 Dec 20; 12(12):1527-1533.
    View in: PubMed
    Score: 0.007
  50. Calvert PA, Northridge DB, Malik IS, Shapiro L, Ludman P, Qureshi SA, Mullen M, Henderson R, Turner M, Been M, Walsh KP, Casserly I, Morrison L, Walker NL, Thomson J, Spence MS, Mahadevan VS, Hoye A, MacCarthy PA, Daniels MJ, Clift P, Davies WR, Adamson PD, Morgan G, Aggarwal SK, Ismail Y, Ormerod JO, Khan HR, Chandran SS, de Giovanni J, Rana BS, Ormerod O, Hildick-Smith D. Percutaneous Device Closure of Paravalvular Leak: Combined Experience From the United Kingdom and Ireland. Circulation. 2016 Sep 27; 134(13):934-44.
    View in: PubMed
    Score: 0.006
  51. Wu SP, Pfeiffer RM, Ahn IE, Mailankody S, Sonneveld P, van Duin M, Munshi NC, Walker BA, Morgan G, Landgren O. Impact of Genes Highly Correlated with MMSET Myeloma on the Survival of Non-MMSET Myeloma Patients. Clin Cancer Res. 2016 Aug 15; 22(16):4039-44.
    View in: PubMed
    Score: 0.006
  52. Rafiq I, Morgan G, Silva Vieira M, Qureshi S, Hussain T. Chronic Occlusion of the Superior Vena Cava Resulting in Cyanosis in an Adult: Unusual Case Highlighting the Value of Collaboration Between Adult and Congenital Cardiology Services. Circ Cardiovasc Interv. 2015 Sep; 8(9):e002163.
    View in: PubMed
    Score: 0.006
  53. Palumbo A, Avet-Loiseau H, Oliva S, Lokhorst HM, Goldschmidt H, Rosinol L, Richardson P, Caltagirone S, Lahuerta JJ, Facon T, Bringhen S, Gay F, Attal M, Passera R, Spencer A, Offidani M, Kumar S, Musto P, Lonial S, Petrucci MT, Orlowski RZ, Zamagni E, Morgan G, Dimopoulos MA, Durie BG, Anderson KC, Sonneveld P, San Miguel J, Cavo M, Rajkumar SV, Moreau P. Revised International Staging System for Multiple Myeloma: A Report From International Myeloma Working Group. J Clin Oncol. 2015 Sep 10; 33(26):2863-9.
    View in: PubMed
    Score: 0.006
  54. Schey S, Brown SR, Tillotson AL, Yong K, Williams C, Davies F, Morgan G, Cavenagh J, Cook G, Cook M, Orti G, Morris C, Sherratt D, Flanagan L, Gregory W, Cavet J. Bendamustine, thalidomide and dexamethasone combination therapy for relapsed/refractory myeloma patients: results of the MUKone randomized dose selection trial. Br J Haematol. 2015 Aug; 170(3):336-48.
    View in: PubMed
    Score: 0.006
  55. Butera G, Morgan GJ, Ovaert C, Anjos R, Spadoni I. Recommendations from the Association of European Paediatric Cardiology for training in diagnostic and interventional cardiac catheterisation. Cardiol Young. 2015 Mar; 25(3):438-46.
    View in: PubMed
    Score: 0.006
  56. Thomson JD, Hildick-Smith D, Clift P, Morgan G, Daniels M, Henderson R, Spence MS, Mahadevan VS, Crossland D, Ormerod O. Patent foramen ovale closure with the Gore septal occluder: initial UK experience. Catheter Cardiovasc Interv. 2014 Feb 15; 83(3):467-73.
    View in: PubMed
    Score: 0.005
  57. Dignan FL, Potter MN, Ethell ME, Taylor M, Lewis L, Brennan J, McNamara L, Evans SO, Riley U, Davies FE, Dearden CE, Morgan GJ, Shaw BE. High readmission rates are associated with a significant economic burden and poor outcome in patients with grade III/IV acute GvHD. Clin Transplant. 2013 Jan-Feb; 27(1):E56-63.
    View in: PubMed
    Score: 0.005
  58. Anoop P, Shaw BE, Riley U, Ethell ME, Taj M, Lancaster DL, Atra A, Saso R, Littlewood S, Mohammed K, Davies F, Treleaven J, Morgan GJ, Potter MN. Clinical profile and outcome of urotheliotropic viral haemorrhagic cystitis following haematopoietic stem cell transplantation: a 7-year tertiary centre analysis. Hematology. 2011 Jul; 16(4):213-20.
    View in: PubMed
    Score: 0.005
  59. Cook G, Liakopoulou E, Pearce R, Cavet J, Morgan GJ, Kirkland K, Lee J, Davies FE, Hall R, Rahemtulla A, Russell N, Marks DI. Factors influencing the outcome of a second autologous stem cell transplant (ASCT) in relapsed multiple myeloma: a study from the British Society of Blood and Marrow Transplantation Registry. Biol Blood Marrow Transplant. 2011 Nov; 17(11):1638-45.
    View in: PubMed
    Score: 0.004
  60. Forsey J, Kenny D, Morgan G, Hayes A, Turner M, Tometzki A, Martin R. Early clinical experience with the new Amplatzer Ductal Occluder II for closure of the persistent arterial duct. Catheter Cardiovasc Interv. 2009 Oct 01; 74(4):615-23.
    View in: PubMed
    Score: 0.004
  61. Chakrabarti S, Morgan GJ, Kenny D, Walsh KP, Oslizlok P, Martin RP, Turner MS, Stuart AG. Initial experience of pacing with a lumenless lead system in patients with congenital heart disease. Pacing Clin Electrophysiol. 2009 Nov; 32(11):1428-33.
    View in: PubMed
    Score: 0.004
  62. Chakrabarti S, Kenny D, Morgan G, Curtis SL, Hamilton MC, Wilde P, Tometzki AJ, Turner MS, Martin RP. Balloon expandable stent implantation for native and recurrent coarctation of the aorta--prospective computed tomography assessment of stent integrity, aneurysm formation and stenosis relief. Heart. 2010 Aug; 96(15):1212-6.
    View in: PubMed
    Score: 0.004
  63. Kenny D, Morgan G, Bajwa A, Farrow C, Parry A, Caputo M, Tometzki A, Martin R. Evolution of transcatheter closure of perimembranous ventricular septal defects in a single centre. Catheter Cardiovasc Interv. 2009 Mar 01; 73(4):568-75.
    View in: PubMed
    Score: 0.004
  64. Gahrton G, Iacobelli S, Bandini G, Björkstrand B, Corradini P, Crawley C, Hegenbart U, Morgan G, Kröger N, Schattenberg A, Schönland SO, Verdonck LF, Volin L, de Witte T, Niederwieser D. Peripheral blood or bone marrow cells in reduced-intensity or myeloablative conditioning allogeneic HLA identical sibling donor transplantation for multiple myeloma. Haematologica. 2007 Nov; 92(11):1513-8.
    View in: PubMed
    Score: 0.003
  65. Willett EV, Smith AG, Dovey GJ, Morgan GJ, Parker J, Roman E. Tobacco and alcohol consumption and the risk of non-Hodgkin lymphoma. Cancer Causes Control. 2004 Oct; 15(8):771-80.
    View in: PubMed
    Score: 0.003
  66. Allan JM, Smith AG, Wheatley K, Hills RK, Travis LB, Hill DA, Swirsky DM, Morgan GJ, Wild CP. Genetic variation in XPD predicts treatment outcome and risk of acute myeloid leukemia following chemotherapy. Blood. 2004 Dec 15; 104(13):3872-7.
    View in: PubMed
    Score: 0.003
  67. Barrans SL, O'Connor SJ, Evans PA, Davies FE, Owen RG, Haynes AP, Morgan GJ, Jack AS. Rearrangement of the BCL6 locus at 3q27 is an independent poor prognostic factor in nodal diffuse large B-cell lymphoma. Br J Haematol. 2002 May; 117(2):322-32.
    View in: PubMed
    Score: 0.002
  68. Lebailly P, Willett EV, Moorman AV, Roman E, Cartwright R, Morgan GJ, Wild CP. Genetic polymorphisms in microsomal epoxide hydrolase and susceptibility to adult acute myeloid leukaemia with defined cytogenetic abnormalities. Br J Haematol. 2002 Mar; 116(3):587-94.
    View in: PubMed
    Score: 0.002
  69. Barrans SL, Carter I, Owen RG, Davies FE, Patmore RD, Haynes AP, Morgan GJ, Jack AS. Germinal center phenotype and bcl-2 expression combined with the International Prognostic Index improves patient risk stratification in diffuse large B-cell lymphoma. Blood. 2002 Feb 15; 99(4):1136-43.
    View in: PubMed
    Score: 0.002
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.

Copyright © 2025 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)